title: [The role of E2 and F2alpha prostaglandins in development of erosive-ulcerative lesions of the gastroduodenal region].
abstract: OBJECTIVE
  To study role of E2 and F2alpha prostaglandins in development of erosive-ulcerative lesions of gastrointestinal tract.
  
  
  METHODS
  were examined patients with mucosal erosive-ulcerative and inflammatory lesions of gastrointestinal tract, as well as patients with osteoarthritis who received selective and non selective NSAIDs. Determination of E2 and F2alpha endogenous PG group was investigated with help of immunefuoration method with help of R&D Systems, Inc. Control group was 15 healthy patients.
  
  
  RESULTS
  in presented work you can find that there is relationship between degree of reduction of PG level and severity of gastrointestinal mucosal lesion area. The lowest values of PGE2 and PG F2alpha observed in patients with gastric ulcer disease, especially during exacerbation. Patients with low PG synthesis in body increases likelihood of gastropathy as to reception of non-selective COX inhibitors, and at receiving selective COX-2 inhibitors.
authors: G G
authors: GG
authors: Varvanina
authors: E V
authors: EV
authors: Tkachenko
authors: V N
authors: VN
authors: Drozdov
mesh_terms: D016022:Case-Control Studies; D051545:Cyclooxygenase 1 / Q000096:biosynthesis; D051546:Cyclooxygenase 2 / Q000096:biosynthesis; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects; D015237:Dinoprost / Q000096:biosynthesis*; D015232:Dinoprostone / Q000096:biosynthesis*; D004382:Duodenitis / Q000139:chemically induced / Q000201:enzymology / Q000378:metabolism*; D005753:Gastric Mucosa / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism; D005756:Gastritis / Q000139:chemically induced / Q000201:enzymology / Q000378:metabolism*; D006801:Humans; D007413:Intestinal Mucosa / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism; D010003:Osteoarthritis / Q000188:drug therapy; D010437:Peptic Ulcer / Q000139:chemically induced / Q000201:enzymology / Q000378:metabolism*
chemical_list: D016861:Cyclooxygenase Inhibitors; D015237:Dinoprost; D051545:Cyclooxygenase 1; D051546:Cyclooxygenase 2; D015232:Dinoprostone